These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 30767565)

  • 1. Galectin-3: A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension.
    Fulton DJR; Li X; Bordan Z; Wang Y; Mahboubi K; Rudic RD; Haigh S; Chen F; Barman SA
    Antioxid Redox Signal; 2019 Nov; 31(14):1053-1069. PubMed ID: 30767565
    [No Abstract]   [Full Text] [Related]  

  • 2. Galectin-3 Promotes ROS, Inflammation, and Vascular Fibrosis in Pulmonary Arterial Hypertension.
    Barman SA; Bordan Z; Batori R; Haigh S; Fulton DJR
    Adv Exp Med Biol; 2021; 1303():13-32. PubMed ID: 33788185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4.
    He J; Li X; Luo H; Li T; Zhao L; Qi Q; Liu Y; Yu Z
    J Am Soc Hypertens; 2017 May; 11(5):275-289.e2. PubMed ID: 28431936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 is expressed in vascular smooth muscle cells and promotes pulmonary hypertension through changes in proliferation, apoptosis, and fibrosis.
    Barman SA; Li X; Haigh S; Kondrikov D; Mahboubi K; Bordan Z; Stepp DW; Zhou J; Wang Y; Weintraub DS; Traber P; Snider W; Jonigk D; Sullivan J; Crislip GR; Butcher JT; Thompson J; Su Y; Chen F; Fulton DJR
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L784-L797. PubMed ID: 30724100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adventitial Fibroblast Nox4 Expression and ROS Signaling in Pulmonary Arterial Hypertension.
    Barman SA; Fulton D
    Adv Exp Med Biol; 2017; 967():1-11. PubMed ID: 29047077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3 mediates pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension.
    Luo H; Liu B; Zhao L; He J; Li T; Zha L; Li X; Qi Q; Liu Y; Yu Z
    J Am Soc Hypertens; 2017 Oct; 11(10):673-683.e3. PubMed ID: 28826890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 aggravates pulmonary arterial hypertension via immunomodulation in congenital heart disease.
    Shen Q; Chen W; Liu J; Liang Q
    Life Sci; 2019 Sep; 232():116546. PubMed ID: 31176777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3- Mediated Transdifferentiation of Pulmonary Artery Endothelial Cells Contributes to Hypoxic Pulmonary Vascular Remodeling.
    Zhang L; Li YM; Zeng XX; Wang XY; Chen SK; Gui LX; Lin MJ
    Cell Physiol Biochem; 2018; 51(2):763-777. PubMed ID: 30463073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure: A Possible Novel Therapeutic Target.
    Omura J; Satoh K; Kikuchi N; Satoh T; Kurosawa R; Nogi M; Ohtsuki T; Al-Mamun ME; Siddique MAH; Yaoita N; Sunamura S; Miyata S; Hoshikawa Y; Okada Y; Shimokawa H
    Circ Res; 2019 Oct; 125(10):884-906. PubMed ID: 31556812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eukaryotic elongation factor 2 kinase mediates monocrotaline-induced pulmonary arterial hypertension via reactive oxygen species-dependent vascular remodeling.
    Kameshima S; Kazama K; Okada M; Yamawaki H
    Am J Physiol Heart Circ Physiol; 2015 May; 308(10):H1298-305. PubMed ID: 25770246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension.
    Li T; Zha L; Luo H; Li S; Zhao L; He J; Li X; Qi Q; Liu Y; Yu Z
    Aging Dis; 2019 Aug; 10(4):731-745. PubMed ID: 31440380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats.
    Schmuck EG; Hacker TA; Schreier DA; Chesler NC; Wang Z
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1005-H1013. PubMed ID: 30822119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension.
    Martínez-Martínez E; Calvier L; Fernández-Celis A; Rousseau E; Jurado-López R; Rossoni LV; Jaisser F; Zannad F; Rossignol P; Cachofeiro V; López-Andrés N
    Hypertension; 2015 Oct; 66(4):767-75. PubMed ID: 26238446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
    Van der Feen DE; Kurakula K; Tremblay E; Boucherat O; Bossers GPL; Szulcek R; Bourgeois A; Lampron MC; Habbout K; Martineau S; Paulin R; Kulikowski E; Jahagirdar R; Schalij I; Bogaard HJ; Bartelds B; Provencher S; Berger RMF; Bonnet S; Goumans MJ
    Am J Respir Crit Care Med; 2019 Oct; 200(7):910-920. PubMed ID: 31042405
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.
    Kurosawa R; Satoh K; Kikuchi N; Kikuchi H; Saigusa D; Al-Mamun ME; Siddique MAH; Omura J; Satoh T; Sunamura S; Nogi M; Numano K; Miyata S; Uruno A; Kano K; Matsumoto Y; Doi T; Aoki J; Oshima Y; Yamamoto M; Shimokawa H
    Circ Res; 2019 Jul; 125(3):309-327. PubMed ID: 31195886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity.
    Martínez-Martínez E; López-Ándres N; Jurado-López R; Rousseau E; Bartolomé MV; Fernández-Celis A; Rossignol P; Islas F; Antequera A; Prieto S; Luaces M; Cachofeiro V
    Hypertension; 2015 Nov; 66(5):961-9. PubMed ID: 26351031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the genome: challenges and potential for epigenetics-driven therapeutic approaches in pulmonary arterial hypertension.
    Hsu JY; Major JL; Riching AS; Sen R; Pires da Silva J; Bagchi RA
    Biochem Cell Biol; 2020 Dec; 98(6):631-646. PubMed ID: 32706995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 contributes to vascular fibrosis in monocrotaline-induced pulmonary arterial hypertension rat model.
    Wang X; Wang Y; Zhang J; Guan X; Chen M; Li Y; Zhang L
    J Biochem Mol Toxicol; 2017 May; 31(5):. PubMed ID: 27870162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension.
    González GE; Rhaleb NE; D'Ambrosio MA; Nakagawa P; Liao TD; Peterson EL; Leung P; Dai X; Janic B; Liu YH; Yang XP; Carretero OA
    Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1287-H1296. PubMed ID: 27496875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial Nox1 oxidase assembly in human pulmonary arterial hypertension; driver of Gremlin1-mediated proliferation.
    Ghouleh IA; Sahoo S; Meijles DN; Amaral JH; de Jesus DS; Sembrat J; Rojas M; Goncharov DA; Goncharova EA; Pagano PJ
    Clin Sci (Lond); 2017 Aug; 131(15):2019-2035. PubMed ID: 28522681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.